{"id":1589743,"url":"http://info.mzalendo.com/api/v0.1/hansard/entries/1589743/?format=json","text_counter":114,"type":"other","speaker_name":"","speaker_title":"","speaker":null,"content":"This stock is sufficient to cover national demand in the period indicated. In regard to the long-term strategy for vaccine supply resilience, there is a bit of history to it. Since 2001, Kenya has been a valued beneficiary of support from Global Alliance for Vaccines and Immunisation (GAVI) to the tune of approximately US$950 million to strengthen The electronic version of the Official Hansard Report is for information purposesonly. A certified version of this Report can be obtained from the Hansard Editor."}